Cirrhotic cardiomyopathy: An endocannabinoid connection?

British Journal of Pharmacology

Volumn 146, Issue 3, 2005, Pages 313-314

  Pacher, Pál ^a   Bátkai, Sándor ^a   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PERTUSSIS TOXIN; RIMONABANT; TETRODOTOXIN; UNCLASSIFIED DRUG;

ALCOHOLIC CARDIOMYOPATHY; ARTERIAL PRESSURE; CARDIOMYOPATHY; DISEASE EXACERBATION; DRUG MECHANISM; ENDOTHELIUM CELL; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; MESENTERIC ARTERY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VASCULAR RESISTANCE;

ANIMALS; CARDIOMYOPATHIES; ENDOCANNABINOIDS; HUMANS; LIVER CIRRHOSIS, EXPERIMENTAL; MYOCARDIAL CONTRACTION; RECEPTOR, CANNABINOID, CB1;

EID: 27144518128     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706332     Document Type: Note

References (13)

1. 1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med., 7, 827-832.
2. BÁTKAI, S., PACHER, P., OSEI-HYIAMAN, D., RADAEVA, S., LIU, J., HARVEY-WHITE, J., OFFERTÁLER, L., MACKIE, K., RUDD, M.A., BUKOSKI, R.D. & KUNOS, G. (2004). Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation, 110, 1996-2002.
3. BONZ, A., LASER, M., KULLMER, S., KNIESCH, S., BABIN-EBELL, J., POPP, V., ERTL, G. & WAGNER, J.A. (2003). Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J. Cardiovasc. Pharmacol., 41, 657-664.
4. DI MARZO, V., BISOGNO, T., DE PETROCELLIS, L., MELCK, D., ORLANDO, P., WAGNER, J.A. & KUNOS, G. (1999). Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem., 264, 258-267.
5. DOMENICALI, M., ROS, J., FERNANDEZ-VARO, G., CEJUDO-MARTIN, P., CRESPO, M., MORALES-RUIZ, M., BRIONES, A.M., CAMPISTOL, J.M., ARROYO, V., VILA, E., RODES, J. & JIMENEZ, W. (2005). Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut, 54, 522-527.
6. GASKARI, S.A., LIU, H., MOEZI, L., LI, Y., BAIK, S.K. & LEE, S.S. (2005). Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br. J. Pharmacol., 146, 315-323 (this issue).
7. GINES, P., QUINTERO, E., ARROYO, V., TERES, J., BRUGUERA, M., RIMOLA, A., CABALLERIA, J., RODES, J. & ROZMAN, C. (1987). Compensated cirrhosis: natural history and prognostic factors. Hepatology, 1, 122-128.
8. 1 receptor. 2004 Symposium on the Cannabinoids. Burlington, Vermont, International Cannabinoid Research Society, p 60.
9. LIU, J., BÁTKAI, S., PACHER, P., HARVEY-WHITE, J., WAGNER, J.A., CRAVATT, B.F., GAO, B. & KUNOS, G. (2003). Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J. Biol. Chem., 278, 45034-45039.
10. MA, Z. & LEE, S.S. (1996). Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology, 24, 451-459.
11. MOLLER, S. & HENRIKSEN, J.H. (2002). Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart, 87, 9-15.
12. PÁCHER, P., BÁTKAI, S. & KUNOS, G. (2005). Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology, 48, 1130-1138.
13. ROS, J., CLARIA, J., TO-FIGUERAS, J., PLANAGUMA, A., CEJUDO-MARTIN, P., FERNANDEZ-VARO, G., MARTIN-RUIZ, R., ARROYO, V., RIVERA, F., RODES, J. & JIMENEZ, W. (2002). Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology, 122, 85-93.